(LDOS) Leidos Holdings - Overview
Sector: Technology | Industry: Information Technology Services | Exchange: NYSE (USA) | Market Cap: 15.850m USD | Total Return: -8.9% in 12m
Avg Turnover: 188M
EPS Trend: 98.8%
Qual. Beats: 1
Rev. Trend: 97.7%
Qual. Beats: 1
Warnings
Below Avwap Earnings
Tailwinds
No distinct edge detected
Leidos Holdings Inc. is a global provider of technology services and solutions primarily serving government agencies and commercial sectors. The company operates through four distinct segments: National Security & Digital, Health & Civil, Commercial & International, and Defense Systems. Its portfolio includes software development, cybersecurity, digital modernization, air traffic control systems, and specialized hardware for airport and border security.
The business model relies heavily on long-term government contracts, which often provide predictable revenue streams and high barriers to entry due to required security clearances and technical expertise. As a primary contractor for the U.S. Department of Defense and intelligence agencies, Leidos operates within the defense and IT services sector, where performance is frequently tied to federal budget cycles and national security priorities.
Investors can evaluate the companys historical performance and valuation metrics on ValueRay to inform their analysis. Founded in 1969 and headquartered in Reston, Virginia, the firm integrates advanced technologies such as artificial intelligence and machine learning into mission-critical infrastructure and defense operations.
- U.S. Department of Defense spending levels dictate long-term contract backlog growth
- Federal digital modernization initiatives accelerate high-margin software and AI revenue
- Geopolitical instability increases global demand for advanced missile defense and ISR systems
- Rising labor costs for specialized technical talent pressure consolidated operating margins
- Health and Civil segment profitability depends on large-scale federal program renewals
| Net Income: 1.42b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 2.26 > 1.0 |
| NWC/Revenue: 7.22% < 20% (prev 9.38%; Δ -2.16% < -1%) |
| CFO/TA 0.13 > 3% & CFO 1.99b > Net Income 1.42b |
| Net Debt (7.10b) to EBITDA (2.38b): 2.98 < 3 |
| Current Ratio: 1.40 > 1.5 & < 3 |
| Outstanding Shares: last quarter (128.0m) vs 12m ago -2.29% < -2% |
| Gross Margin: 17.53% > 18% (prev 0.17%; Δ 1.74k% > 0.5%) |
| Asset Turnover: 121.2% > 50% (prev 128.3%; Δ -7.05% > 0%) |
| Interest Coverage Ratio: 9.98 > 6 (EBITDA TTM 2.38b / Interest Expense TTM 209.0m) |
| A: 0.08 (Total Current Assets 4.40b - Total Current Liabilities 3.15b) / Total Assets 15.4b |
| B: 0.32 (Retained Earnings 4.92b / Total Assets 15.4b) |
| C: 0.15 (EBIT TTM 2.09b / Avg Total Assets 14.3b) |
| D: 0.47 (Book Value of Equity 4.90b / Total Liabilities 10.3b) |
| Altman-Z'' = 3.05 = A |
| DSRI: 1.02 (Receivables 3.03b/2.91b, Revenue 17.3b/16.9b) |
| GMI: 0.98 (GM 17.53% / 17.23%) |
| AQI: 1.21 (AQ_t 0.65 / AQ_t-1 0.54) |
| SGI: 1.02 (Revenue 17.3b / 16.9b) |
| TATA: -0.04 (NI 1.42b - CFO 1.99b) / TA 15.4b) |
| Beneish M = -2.93 (Cap -4..+1) = A |
As of June 01, 2026, the stock is trading at USD 127.80 with a total of 2,599,500 shares traded.
Over the past week, the price has changed by +3.87%,
over one month by -14.35%,
over three months by -28.59% and
over the past year by -8.91%.
Leidos Holdings has received a consensus analysts rating of 4.06. Therefore, it is recommended to buy LDOS.
- StrongBuy: 8
- Buy: 2
- Hold: 7
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 187.8 | 46.9% |
P/E Trailing = 11.5288
P/E Forward = 10.3199
P/S = 0.9147
P/B = 3.1618
P/EG = 2.4573
Revenue TTM = 17.3b USD
EBIT TTM = 2.09b USD
EBITDA TTM = 2.38b USD
Long Term Debt = 6.01b USD (from longTermDebt, last quarter)
Short Term Debt = 320.0m USD (from shortTermDebt, last quarter)
Debt = 7.55b USD (from shortLongTermDebtTotal, last quarter) + Leases 610.0m
Net Debt = 7.10b USD (calculated: Debt 7.55b - CCE 457.0m)
Enterprise Value = 22.9b USD (15.9b + Debt 7.55b - CCE 457.0m)
Interest Coverage Ratio = 9.98 (Ebit TTM 2.09b / Interest Expense TTM 209.0m)
EV/FCF = 12.34x (Enterprise Value 22.9b / FCF TTM 1.86b)
FCF Yield = 8.10% (FCF TTM 1.86b / Enterprise Value 22.9b)
FCF Margin = 10.73% (FCF TTM 1.86b / Revenue TTM 17.3b)
Net Margin = 8.20% (Net Income TTM 1.42b / Revenue TTM 17.3b)
Gross Margin = 17.53% ((Revenue TTM 17.3b - Cost of Revenue TTM 14.3b) / Revenue TTM)
Gross Margin QoQ = 17.30% (prev 16.0%)
Tobins Q-Ratio = 1.49 (Enterprise Value 22.9b / Total Assets 15.4b)
Interest Expense / Debt = 2.77% (Interest Expense 209.0m / Debt 7.55b)
Taxrate = 21.91% (94.0m / 429.0m)
NOPAT = 1.63b (EBIT 2.09b * (1 - 21.91%))
Current Ratio = 1.40 (Total Current Assets 4.40b / Total Current Liabilities 3.15b)
Debt / Equity = 1.51 (Debt 7.55b / totalStockholderEquity, last quarter 5.01b)
Debt / EBITDA = 2.98 (Net Debt 7.10b / EBITDA 2.38b)
Debt / FCF = 3.82 (Net Debt 7.10b / FCF TTM 1.86b)
Total Stockholder Equity = 4.88b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.94% (Net Income 1.42b / Total Assets 15.4b)
RoE = 29.15% (Net Income TTM 1.42b / Total Stockholder Equity 4.88b)
RoCE = 19.15% (EBIT 2.09b / Capital Employed (Equity 4.88b + L.T.Debt 6.01b))
RoIC = 13.46% (NOPAT 1.63b / Invested Capital 12.1b)
WACC = 5.77% (E(15.9b)/V(23.4b) * Re(7.49%) + D(7.55b)/V(23.4b) * Rd(2.77%) * (1-Tc(0.22)))
Discount Rate = 7.49% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -80.90 | Cagr: -3.29%
[DCF] Terminal Value 77.97% ; FCFF base≈1.63b ; Y1≈1.87b ; Y5≈2.76b
[DCF] Fair Price = 273.3 (EV 41.5b - Net Debt 7.10b = Equity 34.4b / Shares 125.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 98.79 | EPS CAGR: 25.39% | SUE: 0.86 | # QB: 1
Revenue Correlation: 97.72 | Revenue CAGR: 6.11% | SUE: 1.09 | # QB: 1
EPS current Quarter (2026-06-30): EPS=2.89 | Chg30d=-4.31% | Revisions=-43% | Analysts=14
EPS next Quarter (2026-09-30): EPS=3.17 | Chg30d=-0.41% | Revisions=-14% | Analysts=14
EPS current Year (2026-12-31): EPS=12.33 | Chg30d=+0.04% | Revisions=-14% | GrowthEPS=+2.8% | GrowthRev=+6.2%
EPS next Year (2027-12-31): EPS=13.18 | Chg30d=-0.19% | Revisions=+14% | GrowthEPS=+6.9% | GrowthRev=+5.0%
[Analyst] Revisions Ratio: -43%